Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7300)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2020 (publication date) through Dec 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Yan MH, Hou XB, Cai BN, Qu BL, Dai XK, Liu F. Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma. World J Clin Cases 2020; 8(24): 6315-6321 [PMID: 33392312 DOI: 10.12998/wjcc.v8.i24.6315] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Yan MH, Hou XB, Cai BN, Qu BL, Dai XK, Liu F. Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma. World J Clin Cases 2020; 8(24): 6315-6321 [PMID: 33392312 DOI: 10.12998/wjcc.v8.i24.6315] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i24/6315.htm |
| Number | Citing Articles |
| 1 |
Daisuke Kawahara, Yuji Murakami, Shota Awane, Yuki Emoto, Kazuma Iwashita, Hikaru Kubota, Ryohei Sasaki, Yasushi Nagata. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model. European Radiology 2023; 34(2): 1200 doi: 10.1007/s00330-023-10020-8
|
| 2 |
Qian-Cheng Du, Xin-Yu Wang, Cheng-Kai Hu, Ling Zhou, Zheng Fu, Shun Liu, Jian Wang, Ying-Ying Ma, Meng-Yao Liu, Hua Yu. Integrative analysis of platelet-related genes for the prognosis of esophageal cancer. World Journal of Clinical Cases 2022; 10(33): 12077-12088 doi: 10.12998/wjcc.v10.i33.12077
|
| 3 |
Yaxing Wei, Wenjie Wu, Yanan Jiang, Hao Zhou, Yin Yu, Lili Zhao, Xiangyu Wu, Xuebo Lu, Qiang Yuan, Zitong Wang, Zigang Dong, Luyun He, Jimin Zhao, Kangdong Liu. Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4. British Journal of Cancer 2022; 126(7): 1037 doi: 10.1038/s41416-021-01651-z
|
| 4 |
Xing Gao, Hidde C G Overtoom, Ben M Eyck, Shi-Han Huang, Daan Nieboer, Pieter C van der Sluis, Sjoerd M Lagarde, Bas P L Wijnhoven, Yin-Kai Chao, Jan J B van Lanschot. Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis. British Journal of Surgery 2024; 111(5) doi: 10.1093/bjs/znae083
|
| 5 |
Chengqiang Li, Yichao Han, Shengguang Zhao, Xiaozheng Kang, Yuyan Zheng, Yuqin Cao, Yan Yan, Liqiang Shi, Xipeng Wang, Tong Lu, Guowen Zou, Huan Li, Jiaming Che, Jie Xiang, Lianggang Zhu, Junbiao Hang, Yajie Zhang, Runsen Jin, Dingpei Han, Xueyu Chen, Hui Jing, Wei Guo, Zenghui Cheng, Liqin Zhao, Xiaoyan Chen, Bentong Yu, Jian Li, Bin Li, Yin Li, Hecheng Li. Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2). Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02477-4
|
| 6 |
Charles E. Gaber, Jyotirmoy Sarker, Abdullah I. Abdelaziz, Ebere Okpara, Todd A. Lee, Samuel J. Klempner, Ryan D. Nipp. Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis. Cancer Medicine 2024; 13(4) doi: 10.1002/cam4.7076
|
| 7 |
Rui-Qin Zhou, Jun Luo, Lin-Jun Li, Ming Du, Qing-Chen Wu. Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02023-5
|
| 8 |
Mengyuan Zhou, Yongliang Yang, Tian Qiu, Yan Wu, Wenting Zhu, Zihan Xu, Xinran Li, Hongyu Huang, Rui Ma, Yingzhi Lu, Zibo Dong. TNK2 promotes the EMT proliferation and invasion of esophageal squamous cell carcinoma by enhancing FOXO1 through the AKT pathway. International Immunopharmacology 2026; 169: 115939 doi: 10.1016/j.intimp.2025.115939
|